ArticleCellular oncology (Dordrecht, Netherlands)2022

Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models.

Shulin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.